When verifying the potential partner proteins Sp1 and MEF 2A (row 2 and 3) expressed in pancreatic carcinoma cells, Sp1 could also be precipitated as a binding partner of NFATc2. This evidence concerns the gene NFATC2 and exocrine pancreatic carcinoma.